相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic Factors Independently Associated With Improved Progression-Free Survival After Surgical Resection in Patients With Spinal Cord Astrocytomas: An Institutional Case Series
Ahmed Helal et al.
OPERATIVE NEUROSURGERY (2022)
H3K27M-mutant glioma in thoracic spinal cord and conus medullaris with pilocytic astrocytoma morphology: case report and review of the literature
Alexis Palpan Flores et al.
BRITISH JOURNAL OF NEUROSURGERY (2021)
CuBlock: a cross-platform normalization method for gene-expression microarrays
Valentin Junet et al.
BIOINFORMATICS (2021)
Algorithmic Annotation of Functional Roles for Components of 3,044 Human Molecular Pathways
Maxim Sorokin et al.
FRONTIERS IN GENETICS (2021)
Molecular diagnostics helps to identify distinct subgroups of spinal astrocytomas
Annamaria Biczok et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Human blood serum can donor-specifically antagonize effects of EGFR-targeted drugs on squamous carcinoma cell growth
Dmitry Kamashev et al.
HELIYON (2021)
RNA sequencing for research and diagnostics in clinical oncology
Anton Buzdin et al.
SEMINARS IN CANCER BIOLOGY (2020)
Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma
Ella L. Kim et al.
CANCERS (2020)
Clinical use of RNA sequencing and oncobox analytics to predict personalized targeted therapeutic efficacy.
Elena Poddubskaya et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Molecular Pathway Activation Markers Are Associated with Efficacy of Trastuzumab Therapy in Metastatic HER2-Positive Breast Cancer Better than Individual Gene Expression Levels
M. Sorokin et al.
BIOCHEMISTRY-MOSCOW (2020)
Cancer gene expression profiles associated with clinical outcomes to chemotherapy treatments
Nicolas Borisov et al.
BMC MEDICAL GENOMICS (2020)
How to do quantile normalization correctly for gene expression data analyses
Yaxing Zhao et al.
SCIENTIFIC REPORTS (2020)
Prognostic factors and nomogram prediction of survival probability in primary spinal cord astrocytoma patients
Chenghua Yuan et al.
JOURNAL OF NEUROSURGERY-SPINE (2020)
Shambhala: a platform-agnostic data harmonizer for gene expression data
Nicolas Borisov et al.
BMC BIOINFORMATICS (2019)
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
Jordi Rodon et al.
NATURE MEDICINE (2019)
Atlas of RNA sequencing profiles for normal human tissues
Maria Suntsova et al.
SCIENTIFIC DATA (2019)
New Paradigm of Machine Learning (ML) in Personalized Oncology: Data Trimming for Squeezing More Biomarkers From Clinical Datasets
Nicolas Borisov et al.
FRONTIERS IN ONCOLOGY (2019)
BRAF Inhibitors in Thyroid Cancer: Clinical Impact, Mechanisms of Resistance and Future Perspectives
Fabiana Crispo et al.
CANCERS (2019)
390OEfficacy and safety of ceritinib in ALK-positive non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): Results from the phase II, ASCEND-7 study
F Barlesi et al.
ANNALS OF ONCOLOGY (2019)
Genomic Landscape of Intramedullary Spinal Cord Gliomas
Ming Zhang et al.
SCIENTIFIC REPORTS (2019)
Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods
Brian J. Haas et al.
GENOME BIOLOGY (2019)
Cerebellar pilocytic astrocytoma in childhood: Investigating the long-term impact of surgery on cognitive performance and functional outcome
Thomas Pletschko et al.
DEVELOPMENTAL NEUROREHABILITATION (2018)
Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugs
Anton Buzdin et al.
SEMINARS IN CANCER BIOLOGY (2018)
Data aggregation at the level of molecular pathways improves stability of experimental transcriptomic and proteomic data
Nicolas Borisov et al.
CELL CYCLE (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development
Ivan V. Ozerov et al.
NATURE COMMUNICATIONS (2016)
DNA methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific hypomethylation signature in pilocytic astrocytomas
Jennie N. Jeyapalan et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activation
Artem Artemov et al.
ONCOTARGET (2015)
Periostin is a novel therapeutic target that predicts and regulates glioma malignancy
Andrei M. Mikheev et al.
NEURO-ONCOLOGY (2015)
Thalidomide as Palliative Treatment in Patients with Advanced Secondary Glioblastoma
Marco Ronald Hassler et al.
ONCOLOGY (2015)
Sorafenib for patients with pretreated recurrent or progressive high-grade glioma: a retrospective, single-institution study
Marco R. Hassler et al.
ANTI-CANCER DRUGS (2014)
Periostin is a new potential prognostic biomarker for glioma
Buxian Tian et al.
TUMOR BIOLOGY (2014)
Signaling pathways activation profiles make better markers of cancer than expression of individual genes
Nikolay M. Borisov et al.
ONCOTARGET (2014)
Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data
Anton A. Buzdin et al.
FRONTIERS IN GENETICS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Perspectives on the immunologic microenvironment of astrocytomas
Iman Hewedi et al.
Cancer Management and Research (2013)
Fos-related antigen 1 (Fra-1) pairing with and transactivation of JunB in GBM cells
Waldemar Debinski et al.
CANCER BIOLOGY & THERAPY (2011)
BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma
Cynthia Hawkins et al.
CLINICAL CANCER RESEARCH (2011)
Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study
Michael T. Milano et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
High-grade intramedullary astrocytomas: 30 years' experience at the Neurosurgery Department of the University of Rome Sapienza Clinical article
Antonino Raco et al.
JOURNAL OF NEUROSURGERY-SPINE (2010)
Merging two gene-expression studies via cross-platform normalization
Andrey A. Shabalin et al.
BIOINFORMATICS (2008)
Phase II study of imatinib in patients with recurrent gliomas of various histologies: A European organisation for research and treatment of cancer brain tumor group study
Eric Raymond et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Successful antiangiogenic therapy for neuroblastoma with thalidomide
Benjamin Gesundheit et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Long-term follow-up of intramedullary spinal cord tumors: A series of 202 cases
A Raco et al.
NEUROSURGERY (2005)
Marked regression of metastatic Pilocytic astrocytoma during treatment with imatinib mesylate (STI-571, Gleevec): A case report and laboratory investigation
ME McLaughlin et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2003)
Controlling the false discovery rate in behavior genetics research
Y Benjamini et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas
HA Fine et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
